Centiva Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170K Hold
20,000
﹤0.01% 1448
2026
Q1
$109K Hold
20,000
﹤0.01% 1374
2025
Q4
$140K Buy
+20,000
New +$157K ﹤0.01% 1037
2025
Q2
Sell
-36,861
Closed -$293K 2031
2025
Q1
$293K Sell
36,861
-207,754
-85% -$2.1M 0.01% 1094
2024
Q4
$2.22M Buy
244,615
+213,234
+680% +$2.06M 0.05% 281
2024
Q3
$288K Buy
+31,381
New +$260K 0.01% 1606
2024
Q2
Sell
-36,857
Closed -$557K 2495
2024
Q1
$557K Buy
+36,857
New +$669K 0.01% 936
2023
Q4
Sell
-21,319
Closed -$396K 2235
2023
Q3
$396K Buy
+21,319
New +$498K 0.01% 1060
2022
Q2
Sell
-39,522
Closed -$2.85M 1978
2022
Q1
$2.85M Sell
39,522
-788
-2% -$56.8K 0.05% 322
2021
Q4
$3.7M Sell
40,310
-4,799
-11% -$574K 0.08% 234
2021
Q3
$5.72M Buy
45,109
+12,254
+37% +$1.78M 0.36% 58
2021
Q2
$5.46M Buy
32,855
+22,011
+203% +$3.57M 0.13% 132
2021
Q1
$1.97M Buy
10,844
+10,494
+2,998% +$2.43M 0.08% 198
2020
Q4
$70K Buy
+350
New +$71.2K ﹤0.01% 855
2019
Q4
Sell
-7,235
Closed -$490K 926
2019
Q3
$490K Buy
+7,235
New +$476K 0.03% 330

Other funds holding TDOC

Centiva Capital's TDOC Position: Q2 2026 in Review

Centiva Capital held its Teladoc Health (TDOC) position steady in Q2 2026 at 20,000 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Centiva Capital first reported a position in TDOC in Q3 2019 and has held it in 15 quarters since. The position peaked at $5.72M in Q3 2021. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Centiva Capital held 20,000 shares of Teladoc Health worth $170K as of Q2 2026.
  • Centiva Capital left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1448 holding.
  • Centiva Capital first reported a position in Teladoc Health in Q3 2019 and has held it in 15 quarters since.
  • Centiva Capital's Teladoc Health position peaked at $5.72M in Q3 2021.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.